US Stock MarketDetailed Quotes

TVGNW TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)

Watchlist
  • 0.019
  • -0.011-36.45%
Close Jul 5 16:00 ET
0Market Cap0.00P/E (TTM)

TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.61%-2.16M
-538.99%-1.38M
-2.22M
-2.18M
95.92%-215.4K
-5.27M
Net income from continuing operations
136.63%11.26M
-101.53%-67.33K
---22.18M
---30.76M
128.26%4.41M
---15.6M
Operating gains losses
--31.97K
105.26%21.75K
----
----
---413.25K
----
Depreciation and amortization
7.78%98.3K
----
---11.74K
--91.21K
----
--9.38K
Other non cash items
-242.13%-40.41M
--256.03K
--20.1M
--28.43M
----
--10.98M
Change In working capital
828.01%517.84K
21.68%897.62K
---125.87K
--55.8K
159.07%737.69K
---1.25M
-Change in receivables
----
---267K
----
----
--0
----
-Change in prepaid assets
-454.52%-250.12K
-68.06%142.67K
--73.92K
--70.55K
927.62%446.61K
---53.96K
-Change in payables and accrued expense
5,149.75%896.6K
251.09%1.02M
---145.12K
--17.08K
134.15%291.08K
---852.33K
-Change in other current assets
-420.68%-68.45K
----
---1
--21.34K
----
---342.65K
-Change in other current liabilities
-13.22%-60.2K
----
---54.67K
---53.17K
----
--0
Cash from discontinued investing activities
Operating cash flow
0.61%-2.16M
-538.99%-1.38M
---2.22M
---2.18M
95.92%-215.4K
---5.27M
Investing cash flow
Cash flow from continuing investing activities
0
342.92M
0
-133K
0
-109.73K
Net PPE purchase and sale
--0
----
--0
---133K
----
---109.73K
Net other investing changes
----
--342.92M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--342.92M
--0
---133K
--0
---109.73K
Financing cash flow
Cash flow from continuing financing activities
-2.83%2.43M
-341.66M
0
2.5M
0
12.5M
Net issuance payments of debt
--0
--1.32M
--0
--2.5M
--0
--12.5M
Net common stock issuance
----
---342.98M
----
----
--0
----
Net preferred stock issuance
--2.2M
----
----
--0
----
----
Net other financing activities
--229.33K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-2.83%2.43M
---341.66M
--0
--2.5M
--0
--12.5M
Net cash flow
Beginning cash position
-80.81%1.05M
-62.51%129.19K
--5.67M
--5.48M
8,878.14%344.58K
--3.84K
Current changes in cash
39.84%265.5K
44.13%-120.35K
---2.22M
--189.87K
-103.03%-215.4K
--7.12M
End cash Position
-76.77%1.32M
-93.16%8.84K
--3.46M
--5.67M
-98.19%129.19K
--7.12M
Free cash flow
6.33%-2.16M
-538.99%-1.38M
---2.22M
---2.31M
96.00%-215.4K
---5.38M
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.61%-2.16M-538.99%-1.38M-2.22M-2.18M95.92%-215.4K-5.27M
Net income from continuing operations 136.63%11.26M-101.53%-67.33K---22.18M---30.76M128.26%4.41M---15.6M
Operating gains losses --31.97K105.26%21.75K-----------413.25K----
Depreciation and amortization 7.78%98.3K-------11.74K--91.21K------9.38K
Other non cash items -242.13%-40.41M--256.03K--20.1M--28.43M------10.98M
Change In working capital 828.01%517.84K21.68%897.62K---125.87K--55.8K159.07%737.69K---1.25M
-Change in receivables -------267K----------0----
-Change in prepaid assets -454.52%-250.12K-68.06%142.67K--73.92K--70.55K927.62%446.61K---53.96K
-Change in payables and accrued expense 5,149.75%896.6K251.09%1.02M---145.12K--17.08K134.15%291.08K---852.33K
-Change in other current assets -420.68%-68.45K-------1--21.34K-------342.65K
-Change in other current liabilities -13.22%-60.2K-------54.67K---53.17K------0
Cash from discontinued investing activities
Operating cash flow 0.61%-2.16M-538.99%-1.38M---2.22M---2.18M95.92%-215.4K---5.27M
Investing cash flow
Cash flow from continuing investing activities 0342.92M0-133K0-109.73K
Net PPE purchase and sale --0------0---133K-------109.73K
Net other investing changes ------342.92M----------------
Cash from discontinued investing activities
Investing cash flow --0--342.92M--0---133K--0---109.73K
Financing cash flow
Cash flow from continuing financing activities -2.83%2.43M-341.66M02.5M012.5M
Net issuance payments of debt --0--1.32M--0--2.5M--0--12.5M
Net common stock issuance -------342.98M----------0----
Net preferred stock issuance --2.2M----------0--------
Net other financing activities --229.33K--------------------
Cash from discontinued financing activities
Financing cash flow -2.83%2.43M---341.66M--0--2.5M--0--12.5M
Net cash flow
Beginning cash position -80.81%1.05M-62.51%129.19K--5.67M--5.48M8,878.14%344.58K--3.84K
Current changes in cash 39.84%265.5K44.13%-120.35K---2.22M--189.87K-103.03%-215.4K--7.12M
End cash Position -76.77%1.32M-93.16%8.84K--3.46M--5.67M-98.19%129.19K--7.12M
Free cash flow 6.33%-2.16M-538.99%-1.38M---2.22M---2.31M96.00%-215.4K---5.38M
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg